Lv4
490 积分 2023-09-19 加入
Advances in research on renal injury in paroxysmal nocturnal hemoglobinuria
4小时前
待确认
Molecular genetics, biochemistry, and biology of PNH
5个月前
已关闭
Advances in research on renal injury in paroxysmal nocturnal hemoglobinuria
5个月前
已完结
Pegcetacoplan: First Approval
5个月前
已完结
Iptacopan: First Approval
5个月前
已完结
Complement Inhibitors in the Management of Complement-Mediated Hemolytic Uremic Syndrome and Paroxysmal Nocturnal Hemoglobinuria
5个月前
已完结
Addition of danicopan to ravulizumab or eculizumab in patients with paroxysmal nocturnal haemoglobinuria and clinically significant extravascular haemolysis (ALPHA): a double-blind, randomised, phase 3 trial
6个月前
已完结
Exploring treatment strategies for paroxysmal nocturnal hemoglobinuria: an overview of registered clinical trials
7个月前
已完结
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial
7个月前
已完结
Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial
11个月前
已完结
皖公网安备34019202002308
